Hengistbury Investment Partners LLP Grifols Sa Transaction History

Hengistbury Investment Partners LLP

  • $244 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$15.15 - $19.78 $31.2 Million - $40.7 Million
-2,056,677 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$16.86 - $19.67 $3.04 Million - $3.55 Million
-180,261 Reduced 8.06%
2,056,677 $37.9 Million
Q3 2020

Nov 16, 2020
BUY
$15.4 - $20.16 $34.4 Million - $45.1 Million
2,236,938 New
2,236,938 $38.8 Million

Others Institutions Holding GRFS

# of Institutions
164
Shares Held
140M
Call Options Held
288K
Put Options Held
389K
View Full List

About Grifols SA

GRFS Quotes by TradingView
  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.21B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Hengistbury Investment Partners LLP Portfolio

Follow Hengistbury Investment Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hengistbury Investment Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Hengistbury Investment Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email